Importantly, these increases did not correlate with serious adverse cardiovascular events in the trial populations, and heart rate typically returned toward baseline levels as treatment continued beyond the dose-escalation phase
Bremelanotide is FDAapproved as Vyleesi for premenopausal women with HSDD, with a labeled ondemand subcutaneous dosing schedule and clear blood pressure and nausea warnings
Glutamine, glycine, N-acetylcysteine, selenium, whey protein isolates with bonded cysteine, GSH and pro-GSH supplementation improves GSH deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, cognition and surfactant regeneration (301307)
It may even help with addiction, according to other research and anecdotal reports